Helen Torley, PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO), sold 30,000 shares at $58.21 ($1.7M) on 2024-09-24, disclosed to the SEC on 2024-09-26.
Scheduled sale ($1.7M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.21 | 10,000 | $582K | 34.1% |
| 2 | $56.34 | 10,000 | $563K | 33.0% |
| 3 | $56.10 | 10,000 | $561K | 32.9% |
| Total | $56.88 avg | 30,000 | $1.7M | 100% |
| Filing → |
| HALO | SELL | 2026-07-09 | $153K | — | Filing → |
| HALO | SELL | 2026-06-03 | $3.4M | — | Filing → |
| HALO | SELL | 2026-05-13 | $3.4M | — | Filing → |